Short Interest in FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) Declines By 52.0%

FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) was the recipient of a significant decrease in short interest in June. As of June 15th, there was short interest totaling 9,169 shares, a decrease of 52.0% from the May 31st total of 19,122 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 5,705 shares, the short-interest ratio is currently 1.6 days.

Institutional Trading of FT Vest U.S. Equity Deep Buffer ETF – October

A hedge fund recently raised its stake in FT Vest U.S. Equity Deep Buffer ETF – October stock. Winnow Wealth LLC raised its position in shares of FT Vest U.S. Equity Deep Buffer ETF – October (BATS:DOCT) by 4,725.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 121,993 shares of the company’s stock after purchasing an additional 119,465 shares during the quarter. FT Vest U.S. Equity Deep Buffer ETF – October accounts for approximately 4.1% of Winnow Wealth LLC’s holdings, making the stock its 5th biggest position. Winnow Wealth LLC owned about 1.48% of FT Vest U.S. Equity Deep Buffer ETF – October worth $5,490,000 at the end of the most recent quarter.

FT Vest U.S. Equity Deep Buffer ETF – October Trading Up 0.5%

Shares of DOCT opened at $46.52 on Tuesday. FT Vest U.S. Equity Deep Buffer ETF – October has a 12 month low of $40.87 and a 12 month high of $46.72. The company has a market cap of $382.86 million, a price-to-earnings ratio of 24.90 and a beta of 0.37. The business’s fifty day simple moving average is $46.14 and its two-hundred day simple moving average is $44.93.

FT Vest U.S. Equity Deep Buffer ETF – October Company Profile

The FT Cboe Vest U.S. Equity Deep Buffer ETF – October (DOCT) is an exchange-traded fund that mostly invests in large cap equity. The fund aims for specific buffered losses and capped gains on the SPY over a specific holdings period. The actively-managed fund holds options and collateral. DOCT was launched on Oct 16, 2020 and is managed by First Trust.